elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33369119-62C93925-4A64-4D88-977E-CB505FF996AE
Q33369119-62C93925-4A64-4D88-977E-CB505FF996AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33369119-62C93925-4A64-4D88-977E-CB505FF996AE
Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options.
P2860
Q33369119-62C93925-4A64-4D88-977E-CB505FF996AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33369119-62C93925-4A64-4D88-977E-CB505FF996AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6ca1c8772a9ecbe273f9256107ec7b902933a1f
P2860
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.